Previous   Next
HomeHealthCoronavirus: India Reports 4,417 New Covid Cases, 23 Deaths

Coronavirus: India Reports 4,417 New Covid Cases, 23 Deaths

India reported 4,417 new coronavirus infections, the lowest in the last three months, taking the tally of COVID-19 cases to 4,44,66,862, according to the Union health ministry data updated on Tuesday.

Active Covid cases have declined to 52,336, while the death toll has climbed to 5,28,030 with 23 fatalities, including one death reconciled by Kerala, the data updated at 8 am.

India had reported 3,714 new cases in a span of 24 hours on June 6.

The active cases comprises 0.12 per cent of the total infections while the national COVID-19 recovery rate has increased to 98.69 per cent, the health ministry said.

Jammu and Kashmir registered 58 new COVID-19 cases on Tuesday, taking the infection tally in the union territory to 4,78,415 with no fresh death due to the coronavirus, an official said here. While seven cases were reported from Jammu division, 51 cases were reported from Kashmir valley, the official said.

The death toll due to the virus was 4,783 as no fresh death was reported from the union territory, he said.

There are 733 active cases of the disease in the union territory, while the number of recoveries has reached 4,72,899, the official said.

The official said there were 51 confirmed cases of mucormycosis (black fungus).

Madhya Pradesh on Tuesday reported 32 COVID-19 cases, which raised the tally to 10,53,705 while the death count remained unchanged at 10,770, a health department official said. The positivity rate stood at 0.7 per cent.

The recovery count went up by 32 to reach 10,42,652, leaving the state with 283 active cases.

With 4,146 samples examined during the day, the number of tests conducted so far in MP has gone up to 2,99,34,537, the official added.

A government release said 12,89,24,700 COVID-19 vaccine doses have been administered so far in Madhya Pradesh, including 24,446 on Tuesday.

Director of Health G Sriramulu in a release said, the 62 new cases surfaced during examination of 1,057 samples in the last 24 hours ending 10 AM today. While Puducherry region accounted for 54 new cases out of the 62, Karaikal and Yanam regions registered four cases each.

Mahe, an enclave of Puducherry in Kerala did not register any fresh case, the Director said.

A total of 251 patients recovered during the last 24 hours and the overall recoveries were 1,70,874. While six patients were in hospitals, the remaining 245 in home quarantine.

The Director said the Health Department has so far examined 23,84,409 samples and found 20,19,259 out of them to be negative.

There was no fresh fatality during the last 24 hours and the death toll remained at 1,969.

Sriramulu said the test positivity rate was 5.87 per cent while fatality and recovery rates were 1,14 per cent and 98.72 per cent respectively.

The Health Department has so far administered 21,04,603 doses which comprised 9,89,789 first doses, 8,21,746 second doses and 2,93,068 booster doses.

Mumbai on Tuesday reported 285 new coronavirus cases, but no fresh death linked to the infection for the first time since August 22, while 516 more patients recovered in the metropolis, said the local civic body. With this, the tally of COVID-19 cases rose to 11,46,725, while the death toll remained unchanged at 19,711, said the Brihanmumbai Municipal Corporation (BMC) in a bulletin.

Mumbai’s overall tally of recuperated patients rose to 11,24,474 after 516 more people recovered from the respiratory illness, said the BMC.

The financial capital has reported zero death linked to the viral infection for the first time since August 22.

The metropolis has a coronavirus recovery rate of 98.1 per cent and is now left with 2,540 active cases, the bulletin said.

The growth rate of COVID-19 cases in Mumbai stood at 0.034 per cent between August 30 and September 5, while the case doubling rate was 2,094 days, it added.

Himachal Pradesh reported 72 fresh COVID-19 cases on Tuesday, pushing the state’s infection count to 3,11,413, an official said. So far, the infection has claimed 4,182 lives in the state.

On the bright side, 99 more patients recovered from the infection, the official said.

The number of active coronavirus cases stands at 521, he added.

The recovery count has reached 3,06,690, the official said.

Meanwhile, A nasal vaccine against Covid-19, developed by Bharat Biotech, has been approved by the drug controller, for “restricted use” among adults “in emergency situation”, said Union Health Minister Dr Mansukh Mandaviya.

In February, in what was the country’s first such anti-Covid drug, Mumbai-based Glenmark launched a nasal spray (branded FabiSpray) in partnership with SaNOtize, for treatment of adult patients.

The company got manufacturing and marketing approvals from the Drugs Controller General of India for its Nitric Oxide Nasal Spray as part of an accelerated approval process. “Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94 per cent in 24 hours and 99 per cent in 48 hours,” the official statement said.

Read more Health News


Please enter your comment!
Please enter your name here

More News

बृजभूषण की जनचेतना महारैली को जिला प्रशासन की अनुमति नही

कैसरगंज के सांसद बृजभूषण शरण सिंह ने 5 जून को जनचेतना महारैली करने का आवाहन किया है। जिसकी उल्टी गिनती शुरू हो गई है।...

वर्ल्ड टेस्ट चैंपियनशिप फाइनल (WTC FINAL) से पहले ऑस्ट्रेलिया ने खेला का ट्रंप कार्ड, होगा फायदा या नुकसान?

वर्ल्ड टेस्ट चैंपियनशिप का फाइनल मैच 7 जून से भारत और ऑस्ट्रेलिया के बीच लंदन के ओवल मैदान में खेला जाएगा . मुकाबला...


More Than A Billion Young People Risk Hearing Loss: Study

More than 1 billion teens and young people are potentially at risk of hearing loss because of their use of headphones and earbuds and...

Vitamin B3 Supplements May Increase Risk of Cancer: Study

New research from the University of Missouri in the US has found that common vitamin B3 dietary supplements can increase the risk of serious...

Does Your Policy Cover Mental Illnesses?

These days mental health issues have become more predominant, especially since the Covid-19 pandemic, due to increased stress and anxiety levels. There could be...